DCF — GLENWOOD REGIONAL MEDICAL CENTER
Enterprise Value: $-187.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-187.3M
Enterprise Value
$-61.7M
PV of Cash Flows
$-125.6M
PV of Terminal Value
$-202.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $190.1M | $-10.3M | -5.0% | $-18.4M | $-16.7M |
| Year 2 | $195.8M | $-8.7M | -4.0% | $-17.0M | $-14.0M |
| Year 3 | $201.6M | $-6.9M | -3.0% | $-15.5M | $-11.6M |
| Year 4 | $207.7M | $-6.1M | -3.0% | $-14.9M | $-10.2M |
| Year 5 | $213.9M | $-5.7M | -3.0% | $-14.8M | $-9.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-187.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$184.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05935419729650764
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5